4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Beijing Biostar Pharmaceuticals Co., Ltd. (2563) operates in the Biotechnology industry and is headquartered in Beijing, China with about 134 employees. Its market capitalization is roughly CNY 1 billion. In the fiscal year ended 2025-12-31, 2563 reported CNY 33M in revenue and (CNY 131M) in net income.
Beijing Biostar Pharmaceuticals Co., Ltd., a synthetic biology-driven biopharmaceutical company, engages in the development, manufacturing, and commercialization of oncology products in the People's Republic of China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | CNY 33M | CNY 72M | CNY 67M | CNY 33M |
| Gross Profit | CNY 31M | CNY 62M | CNY 47M | CNY 24M |
| Operating Income (EBIT) | (CNY 117M) | (CNY 143M) | (CNY 218M) | (CNY 200M) |
| Net Income | (CNY 131M) | (CNY 144M) | (CNY 190M) | (CNY 160M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Dividends Paid | CNY 0M | (CNY 0M) | — | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | CNY 774M | CNY 913M | CNY 772M | CNY 926M |
| Total Liabilities | CNY 108M | CNY 122M | CNY 49M | CNY 58M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2563 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms